Browsing Tag
Chris Anzalone
1 post
Arrowhead Pharmaceuticals advances plozasiran for familial chylomicronemia syndrome with FDA NDA acceptance
Arrowhead Pharmaceuticals, Inc. has taken a major step toward addressing a critical gap in rare disease treatment. The…